Divalproex Sodium Tablet, Delayed Release
Product Images NDC 61919-249

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 61919-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Directrx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

61919 249 60

Packaging label for Divalproex Sodium 500 mg delayed release tablets, 60 tablets per bottle. The label identifies the generic name as Depakote and states each enteric-coated, delayed release tablet contains divalproex sodium USP equivalent to 500 mg valproic acid. The product is distributed by DirectRx and manufactured by U.S. Pharm, USA Inc. The label includes warnings to store below 86°F, keep out of reach of children, and avoid alcohol use during treatment.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.